IVZ vs MNPR · rev $3.57B vs $431.4M cap
Invesco Plc (IVZ) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
IVZ currently screens at market cap $12.76B. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the IVZ and MNPR stock pages for the full models.
Not investment advice.